Heliopolis Microtek Healthcare Limited Filleted accounts for Companies House (small and micro)

HELIOPOLIS MICROTEK HEALTH CARE LIMITED - Company Information

1 false false false false false false false false false true false false false false false false No description of principal activity 2020-12-01 Sage Accounts Production Advanced 2021 - FRS102_2021 280,000 280,000 280,000 xbrli:pure xbrli:shares iso4217:GBP 03869282 2020-12-01 2021-11-30 03869282 2021-11-30 03869282 2019-12-01 2020-11-30 03869282 2020-11-30 03869282 bus:RegisteredOffice 2020-12-01 2021-11-30 03869282 bus:LeadAgentIfApplicable 2020-12-01 2021-11-30 03869282 bus:Director1 2020-12-01 2021-11-30 03869282 core:WithinOneYear 2021-11-30 03869282 core:WithinOneYear 2020-11-30 03869282 core:ShareCapital 2021-11-30 03869282 core:ShareCapital 2020-11-30 03869282 core:RetainedEarningsAccumulatedLosses 2021-11-30 03869282 core:RetainedEarningsAccumulatedLosses 2020-11-30 03869282 core:LandBuildings core:OwnedOrFreeholdAssets 2021-11-30 03869282 core:LandBuildings core:OwnedOrFreeholdAssets 2020-11-30 03869282 bus:SmallEntities 2020-12-01 2021-11-30 03869282 bus:AuditExemptWithAccountantsReport 2020-12-01 2021-11-30 03869282 bus:FullAccounts 2020-12-01 2021-11-30 03869282 bus:SmallCompaniesRegimeForAccounts 2020-12-01 2021-11-30 03869282 bus:PrivateLimitedCompanyLtd 2020-12-01 2021-11-30 03869282 core:LandBuildings core:LongLeaseholdAssets 2020-12-01 2021-11-30

COMPANY REGISTRATION NUMBER: 03869282

HELIOPOLIS MICROTEK HEALTHCARE LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

30 November 2021

HELIOPOLIS MICROTEK HEALTHCARE LIMITED

FINANCIAL STATEMENTS

YEAR ENDED 30 NOVEMBER 2021

Contents	Page

Officers and professional advisers	1

Statement of financial position	2

Notes to the financial statements	3

HELIOPOLIS MICROTEK HEALTHCARE LIMITED

OFFICERS AND PROFESSIONAL ADVISERS

Director	Dr F A M Rizk

Registered office	Lynton House
	7-12 Tavistock Square
	London
	WC1H 9BQ

Accountants	BSG Valentine (UK) LLP
	Chartered Accountants
	Lynton House
	7-12 Tavistock Square
	London
	WC1H 9BQ

HELIOPOLIS MICROTEK HEALTHCARE LIMITED

STATEMENT OF FINANCIAL POSITION

30 November 2021

	2021		2020
Note	£	£	£	£

FIXED ASSETS

Tangible assets	5		280,000		280,000

CURRENT ASSETS

Debtors	6	157,874	122,303
Cash at bank and in hand		54,568	107,201
		---------	---------
		212,442	229,504

CREDITORS: amounts falling due within one year	7	545,981		544,051
		---------		---------
NET CURRENT LIABILITIES			333,539		314,547
			---------		---------
TOTAL ASSETS LESS CURRENT LIABILITIES			( 53,539)		( 34,547)
			--------		--------

CAPITAL AND RESERVES

Called up share capital	100	100
Profit and loss account	( 53,639)	( 34,647)
	--------	--------
SHAREHOLDERS DEFICIT	( 53,539)	( 34,547)
	--------	--------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 30 November 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 16 August 2022 , and are signed on behalf of the board by:

Dr F A M Rizk
Director

Company registration number: 03869282

HELIOPOLIS MICROTEK HEALTHCARE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 30 NOVEMBER 2021

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lynton House, 7-12 Tavistock Square, London, WC1H 9BQ.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Leasehold property	-	15 years straight line method

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 1 (2020: 1 ).

5. Tangible assets

	Freehold property
	£
Cost
At 1 December 2020 and 30 November 2021	280,000
	---------
Depreciation
At 1 December 2020 and 30 November 2021	–
	---------
Carrying amount
At 30 November 2021	280,000
	---------
At 30 November 2020	280,000
	---------

6. Debtors

	2021	2020
	£	£
Amounts owed by group undertakings and undertakings in which the company has a participating interest	157,874	122,303
	---------	---------

7. Creditors: amounts falling due within one year

	2021	2020
	£	£
Other creditors	545,981	544,051
	---------	---------